Profile of Pulmonary Tuberculosis Patients with dan without Diabetes at Prof. Dr. H. Aloei Saboe Regional General Hospital Gorontalo City

Siti Nur Rahmatiya Abas; Sugiyarto Surono; Haafizah Dania; Lolita; Endang Darmawan

doi:10.35451/7aryfn34

Authors

Siti Nur Rahmatiya Abas Universitas Ahmad Dahlan
Sugiyarto Surono Fakultas Sains dan Teknologi Terapan, Universitas Ahmad Dahlan
Haafizah Dania Fakultas Farmasi, Universitas Ahmad Dahlan
Lolita Fakultas Farmasi, Universitas Ahmad Dahlan
Endang Darmawan Fakultas Farmasi, Universitas Ahmad Dahlan

DOI:

https://doi.org/10.35451/7aryfn34

Keywords:

Characteristic, Diabetes Mellitus, Tuberculosis

Abstract

Background: Pulmonary tuberculosis (TB) is still a leading cause of death from infectious diseases worldwide, and diabetes mellitus (DM) exacerbates its impact by increasing the risk of infection, worsening clinical manifestations, and lowering treatment success. Objective: To compare the characteristics of pulmonary TB patients with and without DM. Methods: An observational analytic study with a retrospective design was conducted using medical records of pulmonary TB patients at Prof. Dr. H. Aloei Saboe Hospital, Gorontalo, from January to September 2024. Results: TB-DM is most frequently found in the 55–64 years age group, whereas TB without DM is most prevalent in the 45–54 years group. Female patients dominate the TB-DM group, while male patients are more common in the TB without DM group. Conclusion: that age and sex are important determinants in the distribution of TB-DM and TB without DM, emphasizing the need for integrated screening in patients aged ≥45 years and gender-sensitive interventions for TB control.

Downloads

Download data is not yet available.

References

[1] World Health Organization. 2024 Global Tuberculosis (TB) Report. 2024. 8 p.

[2] Thong PM, Wong YH, Kornfeld H, Goletti D, Ong CWM. Immune dysregulation of diabetes in tuberculosis. Semin Immunol [Internet]. 2025;78(April):101959. Available from: https://doi.org/10.1016/j.smim.2025.101959

[3] Meena LS. Dual burden of Tuberculosis (TB) and Diabetes Mellitus (DM) as the major risk factor for wide range of population. Diabetes Obes Int J. 2020;5(3):1–8.

[4] Arulmohi M, Vinayagamoorthy V, R. DA. Physical Violence Against Doctors: A Content Analysis from Online Indian Newspapers. Indian J Community Med. 2017;42(1):147–50.

[5] Alvarado-Valdivia NT, Flores JA, Inolopú JL, Rosales-Rimache JA. Type 2 diabetes mellitus and recurrent Tuberculosis: A retrospective cohort in Peruvian military workers. J Clin Tuberc Other Mycobact Dis [Internet]. 2024;35(March):100432. Available from: https://doi.org/10.1016/j.jctube.2024.100432

[6] Boadu AA, Yeboah-Manu M, Osei-Wusu S, Yeboah-Manu D. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions. Int J Infect Dis [Internet]. 2024;146:107140. Available from: https://doi.org/10.1016/j.ijid.2024.107140

[7] Bisht MK, Dahiya P, Ghosh S, Mukhopadhyay S. The cause–effect relation of tuberculosis on incidence of diabetes mellitus. Front Cell Infect Microbiol. 2023;13(June):1–15.

[8] Cheng J, Sun YN, Zhang CY, Yu YL, Tang LH, Peng H, et al. Incidence and risk factors of tuberculosis among the elderly population in China: A prospective cohort study. Infect Dis Poverty. 2020;9(1):1–13.

[9] Wu IL, Chen J, Shiau R, Chitnis AS, Jaganath D. Tuberculosis Disease Among Adults Aged 65 Years and Older: Alameda County, California, 2016-2019. Open Forum Infect Dis [Internet]. 2022;9(11):1–8. Available from: https://doi.org/10.1093/ofid/ofac575

[10] Jali M V., Kavital A, Hiremath MB. Challenges of diabetes in elderly TB patients. Indian J Tuberc. 2022;69(January):S264–6.

[11] Evangelista M do SN, Maia R, Toledo JP, Abreu RG de, Barreira D. Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007–2014. Brazilian J Infect Dis [Internet]. 2020;24(2):130–6. Available from: https://doi.org/10.1016/j.bjid.2020.03.005

[12] Geric C, Majidulla A, Tavaziva G, Nazish A, Saeed S, Benedetti A, et al. Artificial intelligence-reported chest X-ray findings of culture-confirmed pulmonary tuberculosis in people with and without diabetes. J Clin Tuberc Other Mycobact Dis [Internet]. 2023;31(March):100365. Available from: https://doi.org/10.1016/j.jctube.2023.100365

[13] Bonavida V, Frame M, Nguyen KH, Rajurkar S, Venketaraman V. Mycobacterium tuberculosis: Implications of Ageing on Infection and Maintaining Protection in the Elderly. Vaccines. 2022;10(11).

[14] Humayun M, Chirenda J, Ye W, Mukeredzi I, Mujuru HA, Yang Z. Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection. Open Forum Infect Dis [Internet]. 2022;9(10):1–9. Available from: https://doi.org/10.1093/ofid/ofac512

[15] Sinulingga AS, Boru Situmorang N, Gabena Siregar M. Evaluasi Penggunaan Obat Antituberkulosis (Oat) Pada Pasien Tb Paru Di Rumah Sakit Grandmed Lubuk Pakam Tahun 2020. J Farm. 2021;3(2):69–73.

[16] Selvaraju S, Velayutham B, Rao R, Rade K, Thiruvengadam K, Asthana S, et al. Prevalence and factors associated with tuberculosis infection in India. J Infect Public Health [Internet]. 2023;16(12):2058–65. Available from: https://doi.org/10.1016/j.jiph.2023.10.009

[17] Oh JY, Rodwell TC, Syed RR, Ko Y, Min J, Kim HW, et al. Unrecognized Tuberculosis: Risk Factors for Smear-Positive/Cavitary Asymptomatic Cases. Open Forum Infect Dis. 2025;12(4):1–7.

[18] Millas I, Duarte Barros M. Estrogen receptors and their roles in the immune and respiratory systems. Anat Rec. 2021;304(6):1185–93.

[19] Meirita E, Sari A. Evaluation of Antibiotics Usage Rationality on Diabetes Mellitus Type Ii Patients At Inpatient Installation of Grandmed Hospital Lubuk Pakam in 2022. J Farm. 2022;5(1):73–9.

[20] Afifah H, Dewi IP, RACHMAWATI E, HOLIDAH D, NORCAHYANTI I. Drug Interaction Study in Type 2 Diabetes Mellitus with Hypertension Patients at X Hospital, Jember Regency. J Farm. 2024;6(2):131–41.

[21] Lambrinoudaki I, Paschou SA, Armeni E, Goulis DG. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol. 2022;18(10):608–22.

[22] Tomic D, Morton JI, Chen L, Salim A, Gregg EW, Pavkov ME, et al. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes Endocrinol. 2022;10(11):795–803.

[23] Nuraisyah F, Juliana N, Astaria D, Khalisah N, Fatih DMF Al, Dewi SK, et al. Risk Factors of Pulmonary Tuberculosis in Type 2 Diabetes Mellitus in Yogyakarta. J Epidemiol Public Heal. 2024;9(2):194–203.

[24] Zaw T, Mahato RK, Laohasiriwong W, Sornlorm K. Determinants of Type II Diabetes Mellitus among Tuberculosis Patients in Yangon Region, Myanmar. Int J Public Heal Asia Pacific. 2024;2(04):39–51.